• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎(NASH)患者肠道微生物组的特征:内源性酒精与 NASH 之间的联系。

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

机构信息

Digestive Diseases and Nutrition Center, Department of Pediatrics, State University of New York at Buffalo, Buffalo, NY 14214, USA.

出版信息

Hepatology. 2013 Feb;57(2):601-9. doi: 10.1002/hep.26093. Epub 2013 Jan 8.

DOI:10.1002/hep.26093
PMID:23055155
Abstract

UNLABELLED

Nonalcoholic steatohepatitis (NASH) is a serious liver disease associated with obesity. Characterized by metabolic syndrome, hepatic steatosis, and liver inflammation, NASH is believed to be under the influence of the gut microflora. Here, the composition of gut bacterial communities of NASH, obese, and healthy children was determined by 16S ribosomal RNA pyrosequencing. In addition, peripheral blood ethanol was analyzed to monitor endogenous ethanol production of patients and healthy controls. UniFrac-based principle coordinates analysis indicated that most of the microbiome samples clustered by disease status. Each group was associated with a unique pattern of enterotypes. Differences were abundant at phylum, family, and genus levels between healthy subjects and obese patients (with or without NASH), and relatively fewer differences were observed between obese and the NASH microbiomes. Among those taxa with greater than 1% representation in any of the disease groups, Proteobacteria, Enterobacteriaceae, and Escherichia were the only phylum, family and genus types exhibiting significant difference between obese and NASH microbiomes. Similar blood-ethanol concentrations were observed between healthy subjects and obese non-NASH patients, but NASH patients exhibited significantly elevated blood ethanol levels.

CONCLUSIONS

The increased abundance of alcohol-producing bacteria in NASH microbiomes, elevated blood-ethanol concentration in NASH patients, and the well-established role of alcohol metabolism in oxidative stress and, consequently, liver inflammation suggest a role for alcohol-producing microbiota in the pathogenesis of NASH. We postulate that the distinct composition of the gut microbiome among NASH, obese, and healthy controls could offer a target for intervention or a marker for disease.

摘要

未加标签

非酒精性脂肪性肝炎(NASH)是一种与肥胖相关的严重肝脏疾病。NASH 的特征是代谢综合征、肝脂肪变性和肝脏炎症,据信其受肠道微生物群的影响。在这里,通过 16S 核糖体 RNA 焦磷酸测序确定了 NASH、肥胖和健康儿童的肠道细菌群落组成。此外,还分析了外周血乙醇以监测患者和健康对照者的内源性乙醇产生。基于 UniFrac 的主坐标分析表明,大多数微生物组样本按疾病状态聚类。每个组都与独特的肠型模式相关。健康受试者与肥胖患者(有或没有 NASH)之间在门、科和属水平上存在差异丰富,而肥胖和 NASH 微生物组之间的差异相对较少。在任何疾病组中占比大于 1%的那些分类群中,变形菌门、肠杆菌科和大肠杆菌是肥胖和 NASH 微生物组之间仅有的表现出显著差异的门、科和属类型。在健康受试者和肥胖非 NASH 患者之间观察到相似的血液乙醇浓度,但 NASH 患者的血液乙醇水平显著升高。

结论

NASH 微生物组中产生酒精的细菌丰度增加、NASH 患者血液乙醇浓度升高以及酒精代谢在氧化应激中的作用已得到充分证实,因此在 NASH 的发病机制中发挥作用的可能是产生酒精的微生物群。我们推测,NASH、肥胖和健康对照之间肠道微生物组的不同组成可能为干预提供目标或作为疾病的标志物。

相似文献

1
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.非酒精性脂肪性肝炎(NASH)患者肠道微生物组的特征:内源性酒精与 NASH 之间的联系。
Hepatology. 2013 Feb;57(2):601-9. doi: 10.1002/hep.26093. Epub 2013 Jan 8.
2
Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.内毒素血症在小儿非酒精性脂肪性肝炎发病机制中并非必需。
J Gastroenterol Hepatol. 2014 Jun;29(6):1292-8. doi: 10.1111/jgh.12510.
3
Gut microbiome and nonalcoholic fatty liver diseases.肠道微生物群与非酒精性脂肪性肝病
Pediatr Res. 2015 Jan;77(1-2):245-51. doi: 10.1038/pr.2014.157. Epub 2014 Oct 13.
4
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.肠道微生物群对非酒精性脂肪性肝炎发生发展的影响。
Eur J Nutr. 2018 Apr;57(3):861-876. doi: 10.1007/s00394-017-1524-x. Epub 2017 Sep 5.
5
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.与儿童非酒精性脂肪性肝病患者的脂肪性肝炎和中重度纤维化相关的微生物组特征。
Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.
6
Intestinal microbiota in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道微生物群。
Hepatology. 2013 Jul;58(1):120-7. doi: 10.1002/hep.26319. Epub 2013 May 14.
7
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.采用综合宏基因组学方法分析小儿非酒精性脂肪肝和肥胖患者的肠道微生物组。
Hepatology. 2017 Feb;65(2):451-464. doi: 10.1002/hep.28572. Epub 2016 Jun 2.
8
[The intestinal microbioma - more than just bacteria in the gut? a new mechanism in the pathogenesis of NASH?].[肠道微生物群——不仅仅是肠道中的细菌?非酒精性脂肪性肝炎发病机制中的一种新机制?]
Z Gastroenterol. 2014 May;52(5):453-5. doi: 10.1055/s-0034-1366044. Epub 2014 May 13.
9
Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis.肥胖和女性性别会增加呼气乙醇浓度:对非酒精性脂肪性肝炎发病机制的潜在影响。
Am J Gastroenterol. 2001 Apr;96(4):1200-4. doi: 10.1111/j.1572-0241.2001.03702.x.
10
The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais.泰国人肠道微生物群与非酒精性脂肪性肝炎的关系。
Biomed Res Int. 2018 Jan 16;2018:9340316. doi: 10.1155/2018/9340316. eCollection 2018.

引用本文的文献

1
Endogenous Ethanol Metabolism and Development of MASLD-MASH.内源性乙醇代谢与代谢相关脂肪性肝病-脂肪性肝炎的发展
Int J Mol Sci. 2025 Sep 4;26(17):8609. doi: 10.3390/ijms26178609.
2
Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies.探索代谢功能障碍相关脂肪性肝病与肠道菌群失调之间的相互作用:病理生理学、临床意义及新兴疗法。
World J Hepatol. 2025 Aug 27;17(8):108730. doi: 10.4254/wjh.v17.i8.108730.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.
代谢功能障碍相关脂肪性肝病(MASLD):肠道微生物群、胰岛素抵抗和糖尿病之间的相互作用
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
4
Development and validation of a multimodal model integrating gut microbiota and metabolite for identifying sarcopenia in patients with MASLD: a study from two centers in China.整合肠道微生物群和代谢物的多模态模型用于识别非酒精性脂肪性肝病患者肌肉减少症的开发与验证:一项来自中国两个中心的研究
Nutr J. 2025 Aug 22;24(1):129. doi: 10.1186/s12937-025-01198-2.
5
Repercussions of gastrointestinal microbiota in postmenopausal osteoporosis.绝经后骨质疏松症中胃肠道微生物群的影响
Womens Health (Lond). 2025 Jan-Dec;21:17455057251363684. doi: 10.1177/17455057251363684. Epub 2025 Aug 19.
6
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease.非酒精性脂肪性肝炎患者的自动酿酒综合征和内源性乙醇生成:来自慢性肝病的视角
Int J Mol Sci. 2025 Jul 30;26(15):7345. doi: 10.3390/ijms26157345.
7
Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies.胃肠道肿瘤中的肠道微生物群:从机制到精准治疗策略
Gut Pathog. 2025 Jul 30;17(1):57. doi: 10.1186/s13099-025-00734-z.
8
Bacteroides- and Prevotella-enriched gut microbial clusters associate with metabolic risks.富含拟杆菌属和普雷沃菌属的肠道微生物群簇与代谢风险相关。
Gut Pathog. 2025 Jul 21;17(1):55. doi: 10.1186/s13099-025-00730-3.
9
The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications.肠道微生物群及其代谢产物的作用:糖尿病及其并发症的新预测指标。
Eur J Med Res. 2025 Jul 9;30(1):601. doi: 10.1186/s40001-025-02824-9.
10
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.代谢功能障碍相关脂肪性肝病及相关肝细胞癌中的肠道微生物群
Nat Rev Gastroenterol Hepatol. 2025 Jul 7. doi: 10.1038/s41575-025-01089-1.